Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian McKeith

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
International Psychogeriatrics|September 3, 2015
Support and information needs following a diagnosis of dementia with Lewy bodiesAlison Killen, Darren Flynn, Aoife De Brún, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026
The utility of a composite endpoint for tracking disease progression in Lewy body dementiaElie Matar, Simon R White, John-Paul Taylor, et al.
Psychological Medicine|November 17, 2017
Non-pharmacological interventions for Lewy body dementia: a systematic reviewMichael H Connors, Lena Quinto, Ian McKeith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2002
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mappingSean J Colloby, John D Fenwick, E David Williams, et al.
The American Journal of Psychiatry|June 19, 2015
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-AnalysisChris Stinton, Ian McKeith, John-Paul Taylor, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 23, 2016
Visual Hallucinations in Eye Disease and Lewy Body DiseasePrabitha Urwyler, Tobias Nef, René Müri, et al.
Neuroscience Letters|November 16, 2004
Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatumMelissa Ray, Iwo Bohr, J Michael McIntosh, et al.
Consciousness and Cognition|November 19, 2002
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortexClive G Ballard, Jennifer A Court, Margaret Piggott, et al.
International Journal of Geriatric Psychiatry|March 23, 2019
Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodiesRory Durcan, Paul C Donaghy, Nicky A Barnett, et al.
Neurology|December 13, 2016
Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLBAlan J Thomas, Johannes Attems, Sean J Colloby, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
International Psychogeriatrics|September 3, 2015
Support and information needs following a diagnosis of dementia with Lewy bodiesAlison Killen, Darren Flynn, Aoife De Brún, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026
The utility of a composite endpoint for tracking disease progression in Lewy body dementiaElie Matar, Simon R White, John-Paul Taylor, et al.
Psychological Medicine|November 17, 2017
Non-pharmacological interventions for Lewy body dementia: a systematic reviewMichael H Connors, Lena Quinto, Ian McKeith, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2002
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mappingSean J Colloby, John D Fenwick, E David Williams, et al.
The American Journal of Psychiatry|June 19, 2015
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-AnalysisChris Stinton, Ian McKeith, John-Paul Taylor, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 23, 2016
Visual Hallucinations in Eye Disease and Lewy Body DiseasePrabitha Urwyler, Tobias Nef, René Müri, et al.
Neuroscience Letters|November 16, 2004
Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatumMelissa Ray, Iwo Bohr, J Michael McIntosh, et al.
Consciousness and Cognition|November 19, 2002
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortexClive G Ballard, Jennifer A Court, Margaret Piggott, et al.
International Journal of Geriatric Psychiatry|March 23, 2019
Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodiesRory Durcan, Paul C Donaghy, Nicky A Barnett, et al.
Neurology|December 13, 2016
Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLBAlan J Thomas, Johannes Attems, Sean J Colloby, et al.
Pageof 8